n-3 polyunsaturated fatty acid supplementation during cancer chemotherapy

n-3 polyunsaturated fatty acid supplementation during cancer chemotherapy

Evidence from several clinical trials suggests that n-3 polyunsaturated fatty acid (n-3 PUFA) supplementation during cancer chemotherapy improves patient outcomes related to chemotherapy tolerability, regardless of the type of chemotherapy used. While the effects of n-3 PUFA supplementation during c...

Full description

Bibliographic Details
Main Authors: Sarah Louise Morland, Karen J.B. Martins, Vera C. Mazurak
Format: Article
Language:English
Published: Elsevier 2016-09-01
Series:Journal of Nutrition & Intermediary Metabolism
Subjects:
Oncology
Cancer
Eicosapentaenoic acid
Docosohexaenoic acid
Fish oil
Clinical trial
Online Access:http://www.sciencedirect.com/science/article/pii/S2352385916300019

Internet

http://www.sciencedirect.com/science/article/pii/S2352385916300019

Similar Items